(Q40429740)

20 September 2017

title

Future vaccine development at NICHD. (English)

1 reference

20 September 2017

2

Rachel Schneerson

1 reference

20 September 2017

John B Robbins

1

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

Annals of the New York Academy of Sciences

20 September 2017

published in

1 reference

20 September 2017

volume

1038

1 reference

20 September 2017

page(s)

49-59

1 reference

Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1315.011

Interim Report of a Controlled Field Trial of Immunization with Capsular Polysaccharides of Haemophilus influenzae Type band Group C Neisseria meningitidis in Mecklenburg County, North Carolina (March 1974-March 1976)

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1315.011

Duration of serum antibodies elicited by Haemophilus influenzae type b capsular polysaccharide alone or conjugated to tetanus toxoid in 18- to 23-month-old children

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1315.011

Considerations for Formulating the Second-Generation Pneumococcal Capsular Polysaccharide Vaccine with Emphasis on the Cross-Reactive Types Within Groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1315.011

Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1315.011

Hypothesis for vaccine development: protective immunity to enteric diseases caused by nontyphoidal salmonellae and shigellae may be conferred by serum IgG antibodies to the O-specific polysaccharide of their lipopolysaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1315.011

Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1315.011

21 January 2018

Identifiers

DOI

10.1196/ANNALS.1315.011

1 reference

release_6yvtnn3hlbblhofkfar5moklre

20 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6yvtnn3hlbblhofkfar5moklre

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference